- Home
- ADXN vs SHPH Comparison
ADXN vs SHPH Comparison
Compare ADXN & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- SHPH
- Stock Information
- Founded
- ADXN 2002
- SHPH 2012
- Country
- ADXN Switzerland
- SHPH United States
- Employees
- ADXN N/A
- SHPH N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- SHPH Health Care
- Exchange
- ADXN Nasdaq
- SHPH Nasdaq
- Market Cap
- ADXN 11.3M
- SHPH 3.3M
- IPO Year
- ADXN N/A
- SHPH 2022
- Fundamental
- Price
- ADXN $10.30
- SHPH $1.29
- Analyst Decision
- ADXN Strong Buy
- SHPH
- Analyst Count
- ADXN 1
- SHPH 0
- Target Price
- ADXN $30.00
- SHPH N/A
- AVG Volume (30 Days)
- ADXN 22.8K
- SHPH 42.2K
- Earning Date
- ADXN 11-11-2024
- SHPH 11-12-2024
- Dividend Yield
- ADXN N/A
- SHPH N/A
- EPS Growth
- ADXN N/A
- SHPH N/A
- EPS
- ADXN 0.05
- SHPH N/A
- Revenue
- ADXN $960,641.00
- SHPH N/A
- Revenue This Year
- ADXN N/A
- SHPH N/A
- Revenue Next Year
- ADXN N/A
- SHPH N/A
- P/E Ratio
- ADXN $1.75
- SHPH N/A
- Revenue Growth
- ADXN N/A
- SHPH N/A
- 52 Week Low
- ADXN $5.00
- SHPH $1.03
- 52 Week High
- ADXN $27.90
- SHPH $4.96
- Technical
- Relative Strength Index (RSI)
- ADXN 54.08
- SHPH 46.55
- Support Level
- ADXN $10.04
- SHPH $1.12
- Resistance Level
- ADXN $10.81
- SHPH $1.26
- Average True Range (ATR)
- ADXN 0.59
- SHPH 0.11
- MACD
- ADXN 0.04
- SHPH 0.05
- Stochastic Oscillator
- ADXN 70.88
- SHPH 59.09
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.